[1]中华医学会.慢性乙型肝炎防治指南[J].中华传染病杂志, 2005, 23 (6) ∶421-432.
|
[2]于岩岩, 斯崇文, 曾争, 等.促肝细胞生长素治疗重型肝炎及慢性重度肝炎的临床研究[J].中华传染病杂志, 2003, 21 (1) ∶54-56.
|
[3]王宝恩, 张定凤.现代肝脏病学[M].北京:科学出版社, 2003:534-559.
|
[4] 孙传兴.临床疾病诊断依据及治愈好转标准[M].北京:人民军医出版社, 1999∶80.
|
[5]Bilous J, Wiersmg S.世界卫生组织乙型肝炎控制目标和策略[J].国外医学.流行病学传染病学分册, 2004, 31 (3) ∶131-132.
|
[6]徐道振.病毒性肝炎临床实践[M].北京:人民卫生出版社, 2006∶293-294.
|
[1] | Gao YuDi, Tian Yuan, Zhang XiangYing, Zhang XiaoHui, Duan ZhongPing, Ren Feng, Chen Yu. Effect of magnesium isoglycyrrhizinate on concanavalin A-induced acute liver failure in mice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1571-1576. doi: 10.3969/j.issn.1001-5256.2020.07.024 |
[2] | Du XiaoFei, Chen Jie, Huang ChunYang, Zhang XiaoDan, Liu Dan, Bian XinQu, Han Ying, Liu YanMin, Dan Jing. Clinical effect and safety of magnesium isoglycyrrhizinate in treatment of autoimmune-like drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(6): 1330-1333. doi: 10.3969/j.issn.1001-5256.2020.06.028 |
[3] | Expert Committee on Clinical Application of Glycyrrhizin Preparation in the Treatment of Liver Diseases. Expert consensus on clinical application of glycyrrhizin preparation in the treatment of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(5): 844-852. doi: 10.3969/j.issn.1001-5256.2016.05.004 |
[4] | Li XiaoHui, Wen Yu, Jin WenHui, Hong Zhuan, Ceng MeiYan, Chen WeiZhu. Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection[J]. Journal of Clinical Hepatology, 2016, 32(1): 143-147. doi: 10.3969/j.issn.1001-5256.2016.01.028 |
[5] | Li XiaoPeng, Li Ming, Lei Wan, Zhang LunLi. Protective effect of magnesium isoglycyrrhizinate in rats with acute liver failure induced by D- galactosamine[J]. Journal of Clinical Hepatology, 2016, 32(3): 545-548. doi: 10.3969/j.issn.1001-5256.2016.03.032 |
[6] | Mao HaiYing, Kang Tao, Yao Ling, Chen Qin. Efficacy of glycyrrhizin in patients with chronic severe hepatitis B:a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(1): 63-67. doi: 10.3969/j.issn.1001-5256.2015.01.014 |
[7] | Ji HuiChun, Liu QingDe, Wang HongQi, Li Juan, Zhu Yun, Sun Yang, Zhou ZhongHai, Liu JunQuan. Clinical efficacy of puerarin combined with compound ammonium glycyrrhetate S in treatment of alcoholic hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(10): 1067-1070. doi: 10.3969/j.issn.1001-5256.2014.10.023 |
[8] | Wang XiaoPeng, Su He, Tian HongWei, Zhang SuYu, Wu ZiYan, An YaLi, Ma YunTao. Clinical efficacy of magnesium isoglycyrrhizinate in treatment of liver injury among patients with obstructive jaundice after percutaneous transhepatic cholangiodrainage[J]. Journal of Clinical Hepatology, 2014, 30(6): 563-566. doi: 10.3969/j.issn.1001-5256.2014.06.022 |
[9] | Luo XiaoKe, Li XiaoLing, Yang LiMing, Wang XiaoHong. Efficacy of magnesium isoglycyrrhizinate in treatment of hepatitis E with severe jaundice[J]. Journal of Clinical Hepatology, 2014, 30(6): 537-539. doi: 10.3969/j.issn.1001-5256.2014.06.014 |
[10] | Xu ZhongNan, Wu XiMing, Wang Pei, Zhang XiQuan, Xia ChunGuang, Wang XunQiang, Wang Yang, Zhan XiaoLe, Qu Ying, Xu MingYi, Lu LunGen. 18α glycyrrhizic acid in the treatment of acute liver injury induced by D-galactosamine in rats[J]. Journal of Clinical Hepatology, 2012, 28(1): 63-65+70. |
[11] | Jing XiaoZhen, Liu Jing, Qian Hai. The therapeutic efficacy of magnesium isoglycyrrhizinate on rats with non alcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2011, 27(3): 295-297. |
[12] | Suo HaiFen, Zhu YaoJu. Effect of sophocarpidine and diammonium glycyrrhizinate injection on hepatic fibrosis and the content of interferon-γ of chronicity type B Hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(2): 196-198. |
[16] | Li YunRu, Wang WenBing, Zhang LiYing, Ou YuNi, Xie Wen, Wei Lai. The analysis of efficacy of glycyrrhizin therapy for autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 117-118. |
[18] | Yin HeKun, Li QiXiang, Luo Dan. The clinical study of L-ornithine-L-aspartate combined with SNMC for hepatic encephalopathy of liver cirrhosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 268-269. |
[20] | Li YongXin, Gao QingWei, Wang YingLan. Analysis on clinical efficacy of Thiamine and Drammonium glycyrrhizinate concerning the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2003, 19(4): 226-227. |